Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months. 1996

S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
Department of Pediatrics, Children's Hospital of Michigan, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, 48201, USA.

OBJECTIVE To evaluate the effect of antenatal phenobarbital (PB) therapy on neurodevelopmental outcome at 36 months. METHODS Prospective, randomized, controlled trial. METHODS Single-institution study. SUBJECT AND INTERVENTIONS: Children born to women who participated in the study evaluating the effect of antenatal phenobarbital (PB) on neonatal intracranial hemorrhage were prospectively followed to 3 years of age. METHODS Physical growth, neurologic examinations, and developmental testing (McCarthy Scales of Children's Abilities). Comparisons between groups were made on all children and those born to multiple gestations. RESULTS Forty-one children born to women who received 10 mg/kg PB before delivery and 55 children in the control group were evaluated. Three children, all in the control group, had growth parameters (height, weight, and head circumference) below the fifth percentile. The McCarthy General Cognitive Index (standard, 100 +/- 16) was 93 +/- 20 in the PB group and 85 +/- 18 in the control group. The subscores tended to be higher in the PB group than in the control group, with higher quantitative scores in the PB group (44 +/- 11 vs 39 +/- 8). Neurologic deficits were noted in 2 of 41 in the PB group and in 6 of 55 in the control group. CONCLUSIONS Infants born to women who received antenatal PB therapy had similar neurodevelopmental outcomes as infants born to women who did not receive PB. No adverse effects of PB exposure were detected.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D009420 Nervous System The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed) Nervous Systems,System, Nervous,Systems, Nervous
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011272 Pregnancy, Multiple The condition of carrying two or more FETUSES simultaneously. Multiple Pregnancy,Multiple Pregnancies,Pregnancies, Multiple
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective

Related Publications

S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
May 1997, Pediatrics,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
May 1996, Pediatrics,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
July 2002, American journal of obstetrics and gynecology,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
May 2023, Children (Basel, Switzerland),
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
January 1990, Brain & development,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
May 2005, Developmental medicine and child neurology,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
November 2023, Journal of perinatology : official journal of the California Perinatal Association,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
December 2021, Acta neurologica Belgica,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
December 2012, Diabetes technology & therapeutics,
S Shankaran, and E Woldt, and J Nelson, and M Bedard, and V Delaney-Black
July 2014, Thyroid : official journal of the American Thyroid Association,
Copied contents to your clipboard!